Saint Vincent and the Grenadines vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Saint Vincent and the Grenadines
100.0%
in 2023
Syria
100.0%
in 2021
Saint Vincent and the Grenadines rank
1st
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Saint Vincent and the Grenadines
- Syria
How they compare
Saint Vincent and the Grenadines currently reports 100.0% against 100.0% in Syria, a difference of 0.0%.
Across all 6 years both countries report, Syria has been ahead every year.
Saint Vincent and the Grenadines ranks 1st and Syria ranks 1st of 144 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.0% | 100.0% | 29.0% | Syria |
| 2010s | 82.3% | 100.0% | 17.7% | Syria |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Saint Vincent and the Grenadines or Syria?
- Saint Vincent and the Grenadines, at 100.0% against 100.0% in Syria as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Saint Vincent and the Grenadines and Syria?
- 0.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Syria?
- 6 years are reported by both, from 2007 to 2021.
- How do Saint Vincent and the Grenadines and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Saint Vincent and the Grenadines ranks 1st and Syria ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.